Summary

• The most common manifestations are flushing, dilated prominent telangiectases (primarily on the face), persistent facial erythema, inflammatory papules, and pustules on the peri-orificial face.
• Prominence of sebaceous glands on the nose may result in fibrosis and rhinophyma.
• The diagnosis is usually clinical.
• Subtypes include erythematotelangiectatic rosacea (subtype 1), papulopustular rosacea (subtype 2), phymatous rosacea (subtype 3), and ocular rosacea (subtype 4).
• Avoidance of triggers is key to the management of the disease.
• Treatment depends on the subtype. Typically, mild disease is initially treated with topical metronidazole or oral tetracyclines. Other antibiotics and anti-inflammatory agents can be used as adjuncts.